货号:GS40803
Vorsetuzumab (PRO-131921) is an investigational humanized monoclonal antibody that targets CD70, a member of the tumor necrosis factor (TNF) superfamily. It is being developed as an antibody-drug conjugate (ADC) or naked antibody for the treatment of CD70-expressing cancers, such as renal cell carcinoma and non-Hodgkin lymphoma, aiming to directly inhibit tumor growth or deliver cytotoxic payloads.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯